Redeye remains optimistic about the prospects of Stille following its Q2 report. The report aligned well with our estimates, and on the back of the S&T acquisition, we raise our Base Case.
ANNONS
Redeye remains optimistic about the prospects of Stille following its Q2 report. The report aligned well with our estimates, and on the back of the S&T acquisition, we raise our Base Case.